Aarti Pharmalabs Limited announced the outcome of its Board Meeting held on May 25, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of Rs. 2/- per equity share was recommended, subject to shareholder approval. Key appointments including Cost Auditor and Internal Auditor were also finalized, alongside the designation of new Senior Management Personnel.
Board Meeting Outcomes
On May 25, 2026, Aarti Pharmalabs Limited’s Board of Directors convened to review and approve crucial financial and operational matters. The meeting, which commenced at 14:00 hours and concluded at 18:30 hours, saw the approval of the audited standalone and consolidated financial results for the fiscal year ending March 31, 2026.
Financial Highlights and Dividend
The audited financial results for the quarter and the full financial year ended March 31, 2026, were approved upon the recommendation of the Audit Committee. The company also proposed a final dividend of Rs. 2/- per equity share (Rupees Two only), with a face value of Rs. 5/- each, for the financial year ended March 31, 2026. This dividend is contingent upon the approval of shareholders at the upcoming Annual General Meeting.
Key Appointments and Designations
Several important appointments and re-appointments were confirmed during the meeting:
- Cost Auditor: Smt. Ketki D. Visariya has been re-appointed as the Cost Auditor for the Financial Year 2026-27.
- Internal Auditor: Manish Modi & Associates has been re-appointed as the Internal Auditor for the Financial Year 2026-27.
- Senior Management Personnel: Mr. Sachin Patil (Head – Exports) and Mr. Rajendra Pagare (Head – Operations & Compliance) have been designated as Senior Management Personnel, effective May 25, 2026.
Audited Financials Overview (Standalone)
The standalone financial statements for the year ended March 31, 2026, report a total income of Rs. 181,287.50 lakhs and total expenses of Rs. 157,584.11 lakhs. The net profit before exceptional items and tax stood at Rs. 23,703.39 lakhs. After accounting for tax expenses of Rs. 5,803.70 lakhs, the net profit for the period was Rs. 17,620.20 lakhs. Earnings per equity share (diluted) were reported at Rs. 19.42.
Audited Financials Overview (Consolidated)
On a consolidated basis for the year ended March 31, 2026, the company reported total income of Rs. 182,918.89 lakhs and total expenses of Rs. 160,147.11 lakhs. The net profit before exceptional items and tax was Rs. 23,292.12 lakhs. After tax expenses of Rs. 5,821.39 lakhs, the consolidated net profit for the period amounted to Rs. 17,470.73 lakhs. The consolidated earnings per equity share (diluted) stood at Rs. 19.25.
Balance Sheet Highlights (Standalone)
As of March 31, 2026, the standalone total assets were valued at Rs. 332,776.47 lakhs, with total equity standing at Rs. 198,235.06 lakhs. Non-current liabilities amounted to Rs. 41,953.10 lakhs, and current liabilities were Rs. 92,588.32 lakhs.
Balance Sheet Highlights (Consolidated)
The consolidated balance sheet as of March 31, 2026, shows total assets of Rs. 348,170.59 lakhs. Total equity was Rs. 212,460.47 lakhs. Non-current liabilities totaled Rs. 41,953.10 lakhs, while current liabilities stood at Rs. 93,757.01 lakhs.
Cash Flow Statement Summary (Standalone)
The standalone cash flow from operating activities for the year ended March 31, 2026, generated Rs. 25,725.77 lakhs. Investing activities resulted in a net cash outflow of Rs. 42,514.02 lakhs, while financing activities generated Rs. 17,058.42 lakhs. The net increase in cash and cash equivalents was Rs. 270.16 lakhs.
Cash Flow Statement Summary (Consolidated)
For the year ended March 31, 2026, consolidated cash flow from operating activities was Rs. 26,193.15 lakhs. Investing activities showed a net cash outflow of Rs. 43,071.71 lakhs, and financing activities generated Rs. 17,058.22 lakhs. The net increase in cash and cash equivalents was Rs. 179.66 lakhs.
Auditor’s Report and Declaration
The independent auditors, Gokhale & Sathe, have issued an audit report with an unmodified opinion on the standalone and consolidated financial results for the year ended March 31, 2026. This declaration confirms that the financial results presented are true and fair, and in compliance with applicable accounting standards and regulations.
Emphasis of Matter
A note highlights the recognition of a foreign exchange derivative contract during the year ended March 31, 2026. This contract, entered into earlier, was not initially included in fair value calculations. The Q3 FY 2025-26 figures were restated to reflect this impact, and the auditor’s opinion remains unmodified in this regard.
Source: BSE
